Cite

HARVARD Citation

    Goto, R. et al. (2017). Cost analysis of leuprorelin acetate in Japanese prostate cancer patients: comparison between 6-month and 3-month depot formulations. Journal of medical economics. pp. 1155-1162. [Online]. 
  
Back to record